Keytruda CAS 1374853-91-4 Pembrolizumab

Model: MOS-new 4
Place of Origin: Zhejiang,China (Mainland)
Name: Keytruda
Name 1: Pembrolizumab
CAS: 1374853-91-4


skype basketAdd to Basket  Edit

Share |

Product Description

Payment & Shipping Terms Supply Capacity
Trade Term:FOB,CIF,DDPProduction Capacity:1kg/year
Payment Terms:T/T, WUPacking:according to the...
Min. Order:1 GramDelivery Date:7 days
Means of Transport:Ocean, Air, Land


CAS: 1374853-91-4

As a humanized anti-pd1 monoclonal antibody, palmdrine (mk-3475, commodity name Keytruda, MSD) was approved by the food and drug administration (FDA) in September 2014 for the treatment of advanced or unresectable malignant melanoma as an immune checkpoint inhibitor (ICB). However, it has been found that pd-1 inhibitors can produce the side effects of autoimmune injury to the human body's multiple systems, such as hepatitis, pneumonia and myocardial injury.

Adaptation disease

1) unresectable or metastatic melanoma and plymma after disease progression and, such as BRAF V600 positive mutation.
2) fda-approved tests identified metastatic NSCLC and disease progression after chemotherapy with or with platinum-based chemotherapy. Patients treated with KEYTRUDA before fda-approved therapy had EGFR or ALK genomic tumor distortion in these patients.

Category: Hot anti-cancer medicines

Related Category: Pharmaceutical Intermediates  Customized Pharmaceutical API  Other Pharmaceutical API  Veterinary Medicine API  Diagnostic Agents API 

Offline Showroom in USA
QR Code